Follicle-stimulating hormone associates with metabolic factors in postmenopausal women

References

• Kassi E, Pervanidou P, Kaltsas G, et al. Metabolic syndrome: definitions and controversies. BMC Med. 2011;9:48.
   PubMed Web of Science ®Google Scholar
• Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120:1640–1645.
   PubMed Web of Science ®Google Scholar
• Xi B, He D, Hu Y, et al. Prevalence of metabolic syndrome and its influencing factors among the Chinese adults: the China Health and Nutrition Survey in 2009. Prevent Med. 2013;57:867–871.
   PubMed Web of Science ®Google Scholar
• Grooms KN, Ommerborn MJ, Pham DQ, et al. Dietary fiber intake and cardiometabolic risks among US adults, NHANES 1999-2010. Am J Med. 2013;126:1059–1067;e1–e4.
   PubMed Web of Science ®Google Scholar
• Vishram JK, Borglykke A, Andreasen AH, et al. Impact of age and gender on the prevalence and prognostic importance of the metabolic syndrome and its components in Europeans. The MORGAM Prospective Cohort Project. PLoS One. 2014;9:e107294.
   PubMed Web of Science ®Google Scholar
• Pucci G, Alcidi R, Tap L, et al. Sex- and gender-related prevalence, cardiovascular risk and therapeutic approach in metabolic syndrome: a review of the literature. Pharmacol Res. 2017;120:34–42.
   PubMed Web of Science ®Google Scholar
• Stefanska A, Bergmann K, Sypniewska G. Metabolic syndrome and menopause: pathophysiology, clinical and diagnostic significance. Adv Clin Chem. 2015;72:1–75.
   PubMed Web of Science ®Google Scholar
• Shah D. The Annual Conference of the British Menopause Society - June 2010. J Midlife Health. 2010;1:48–50.
   PubMedGoogle Scholar
• Park YW, Zhu S, Palaniappan L, et al. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med. 2003;163:427–436.
   PubMed Web of Science ®Google Scholar
• Creatsa M, Armeni E, Stamatelopoulos K, et al. Circulating androgen levels are associated with subclinical atherosclerosis and arterial stiffness in healthy recently menopausal women. Metab Clin Exp. 2012;61:193–201.
   PubMed Web of Science ®Google Scholar
• Litwak SA, Wilson JL, Chen W, et al. Estradiol prevents fat accumulation and overcomes leptin resistance in female high-fat diet mice. Endocrinology. 2014;155:4447–4460.
   PubMed Web of Science ®Google Scholar
• Olszanecka A, Kawecka-Jaszcz K, Czarnecka D. Association of free testosterone and sex hormone binding globulin with metabolic syndrome and subclinical atherosclerosis but not blood pressure in hypertensive perimenopausal women. Arch Med Sci. 2016;12:521–528.
   PubMed Web of Science ®Google Scholar
• Sun L, Peng Y, Sharrow AC, et al. FSH directly regulates bone mass. Cell. 2006;125:247–260.
   PubMed Web of Science ®Google Scholar
• Coorperative Meta-Analysis Group of China Obesity Task Force. Predictive values of body mass index and waist circumference to risk factors of related diseases in Chinese adult population (In Chinese.). Chin J Epidemical. 2002;23:5–10.
   Google Scholar
• Wang N, Kuang L, Han B, et al. Follicle-stimulating hormone associates with prediabetes and diabetes in postmenopausal women. Acta Diabetol. 2016;53:227–236.
   PubMed Web of Science ®Google Scholar
• Wang N, Shao H, Chen Y, et al. Follicle-stimulating hormone, its association with cardiometabolic risk factors, and 10-year risk of cardiovascular disease in postmenopausal women. J Am Heart Assoc. 2017;6:e005918.
   PubMed Web of Science ®Google Scholar
• Sowers M, Zheng H, Tomey K, et al. Changes in body composition in women over six years at midlife: ovarian and chronological aging. J Clin Endocrinol Metab. 2007;92:895–901.
   PubMed Web of Science ®Google Scholar
• Liu P, Ji Y, Yuen T, et al. Blocking FSH induces thermogenic adipose tissue and reduces body fat. Nature. 2017;546:107–112.
   PubMed Web of Science ®Google Scholar
• Key TJ, Appleby PN, Reeves GK, et al. Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst. 2003;95:1218–1226.
   PubMed Web of Science ®Google Scholar
• Chu MC, Rath KM, Huie J, et al. Elevated basal FSH in normal cycling women is associated with unfavourable lipid levels and increased cardiovascular risk. Human Reprod. 2003;18:1570–1573.
   PubMed Web of Science ®Google Scholar
• Derby CA, Crawford SL, Pasternak RC, et al. Lipid changes during the menopause transition in relation to age and weight: the Study of Women's Health Across the Nation. Am J Epidemiol. 2009;169:1352–1361.
   PubMed Web of Science ®Google Scholar
• Song Y, Wang ES, Xing LL, et al. Follicle-stimulating hormone induces postmenopausal dyslipidemia through inhibiting hepatic cholesterol metabolism. J Clin Endocrinol Metabol. 2016;101:254–263.
   PubMed Web of Science ®Google Scholar
• Watanobe H, Hayakawa Y. Hypothalamic interleukin-1 beta and tumor necrosis factor-alpha, but not interleukin-6, mediate the endotoxin-induced suppression of the reproductive axis in rats. Endocrinology. 2003;144:4868–4875.
   PubMed Web of Science ®Google Scholar
• Taddei S. Blood pressure through aging and menopause. Climacteric. 2009;12:36–40.
   PubMed Web of Science ®Google Scholar
• Pu D, Tan R, Yu Q, et al. Metabolic syndrome in menopause and associated factors: a meta-analysis. Climacteric. 2017;20:583–591.
   PubMed Web of Science ®Google Scholar
• Yang J. Elevated follicle-stimulating hormone induces postmenopausal vascular dysfunction by promoting adrenal catecholamine synthesis (In Chinese) [PhD thesis]. Zhejiang Sheng: Zhejiang University; 2014.
   Google Scholar